US Patent 7964360 Uncoupled collagen synthesis and degradation assays
Patent 7964360 was granted and assigned to Barnes-Jewish Hospital on June, 2011 by the United States Patent and Trademark Office.
All edits
The invention relates to methods for determining the progression of cartilage degeneration diseases, such as osteoarthritis and rheumatoid arthritis, by quantitating collagen synthesis and degradation markers in patient samples. One can determine whether a cartilage degeneration condition is progressing, regressing, or remaining stable by quantitating collagen synthesis and degradation markers in patient samples and comparing the value obtained to a reference value. When a joint affected by cartilage degeneration in question expresses collagen synthesis and degradation markers, a change in this value is indicative of a change in the progression of the cartilage degeneration condition. The methods and apparatus of the invention allow accurate determination of the therapeutic effects certain cartilage degeneration drug treatments, including osteoarthritis and rheumatoid arthritis drug treatments, so are also useful for pharmaceutical efficacy studies in mammals.
US Patent 07964360 Uncoupled collagen synthesis and degradation assays US Patent 7964360 Uncoupled collagen synthesis and degradation assays
US Patent 07964360 Uncoupled collagen synthesis and degradation assays
Find more entities like US Patent 7964360 Uncoupled collagen synthesis and degradation assays
